You have no items in your shopping cart.
All Products
Recombinant Human PIP4K2A (C-6His) [orb2994493]Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 47.3 KDa. Observed: 52-58 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg- Recombinant Human Serpin B9 (C-6His) [orb2994494]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 43.4 KDa. Observed: 35-40 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human PRKAR1A (C-6His) [orb2994495]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 44 KDa. Observed: 45-55 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human GFRA2 (C-Fc-6His) [orb2994496]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 74.7 KDa. Observed: 120 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human IL-12B [orb2994497]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 34.6 KDa. Observed: 40-47 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human CNTN2 (C-6His) [orb2994498]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 108.5 KDa. Observed: 110-140 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Mouse EFNB1 (C-Fc-6His) [orb2994499]
Predicted: 49.8 KDa. Observed: 58-80 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human Nectin-4 (C-6His) [orb2994500]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 35.3 KDa. Observed: 40-47 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Mouse CPA2 (C-6His) [orb2994501]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 46.2 KDa. Observed: 41-50 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human CDH16 (C-6His) [orb2994502]
Greater than 75% as determined by reducing SDS-PAGE.
Predicted: 84.4 KDa. Observed: 90-115 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg